Structure

Physi-Chem Properties

Molecular Weight:  582.14
Volume:  549.993
LogP:  3.06
LogD:  1.377
LogS:  -5.597
# Rotatable Bonds:  5
TPSA:  231.51
# H-Bond Aceptor:  13
# H-Bond Donor:  8
# Rings:  5
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.151
Synthetic Accessibility Score:  4.349
Fsp3:  0.276
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.475
MDCK Permeability:  5.621944183076266e-06
Pgp-inhibitor:  0.892
Pgp-substrate:  0.068
Human Intestinal Absorption (HIA):  0.871
20% Bioavailability (F20%):  0.035
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.004
Plasma Protein Binding (PPB):  98.74958038330078%
Volume Distribution (VD):  0.496
Pgp-substrate:  1.5229289531707764%

ADMET: Metabolism

CYP1A2-inhibitor:  0.284
CYP1A2-substrate:  0.046
CYP2C19-inhibitor:  0.022
CYP2C19-substrate:  0.052
CYP2C9-inhibitor:  0.307
CYP2C9-substrate:  0.067
CYP2D6-inhibitor:  0.015
CYP2D6-substrate:  0.128
CYP3A4-inhibitor:  0.116
CYP3A4-substrate:  0.056

ADMET: Excretion

Clearance (CL):  3.114
Half-life (T1/2):  0.081

ADMET: Toxicity

hERG Blockers:  0.061
Human Hepatotoxicity (H-HT):  0.043
Drug-inuced Liver Injury (DILI):  0.983
AMES Toxicity:  0.859
Rat Oral Acute Toxicity:  0.013
Maximum Recommended Daily Dose:  0.02
Skin Sensitization:  0.174
Carcinogencity:  0.193
Eye Corrosion:  0.003
Eye Irritation:  0.68
Respiratory Toxicity:  0.012

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC114257

Natural Product ID:  NPC114257
Common Name*:   Bulbineloneside D
IUPAC Name:   1-[3-acetyl-2,6-dihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-4,5-dihydroxy-2-methylanthracene-9,10-dione
Synonyms:   Bulbineloneside D
Standard InCHIKey:  AOJYFODHRHWWEN-GQUXZSRASA-N
Standard InCHI:  InChI=1S/C29H26O13/c1-9-6-13(33)21-22(23(35)11-4-3-5-12(32)19(11)26(21)38)17(9)20-14(34)7-15(18(10(2)31)25(20)37)41-29-28(40)27(39)24(36)16(8-30)42-29/h3-7,16,24,27-30,32-34,36-37,39-40H,8H2,1-2H3/t16-,24-,27+,28-,29-/m1/s1
SMILES:  OC[C@H]1O[C@@H](Oc2cc(O)c(c(c2C(=O)C)O)c2c(C)cc(c3c2C(=O)c2cccc(c2C3=O)O)O)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL447622
PubChem CID:   10008440
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000018] Anthracenes
        • [CHEMONTID:0000151] Anthraquinones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6812 Bulbine frutescens Species Xanthorrhoeaceae Eukaryota n.a. root n.a. PMID[12193014]
NPO19263 Bulbinella floribunda Species Asphodelaceae Eukaryota roots n.a. n.a. PMID[12828488]
NPO6812 Bulbine frutescens Species Xanthorrhoeaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO19263 Bulbinella floribunda Species Asphodelaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT924 Cell Line HSC-2 Homo sapiens IC50 > 120.0 ug.mL-1 PMID[570533]
NPT839 Cell Line L6 Rattus norvegicus IC50 = 90.0 ug.mL-1 PMID[570534]
NPT27 Others Unspecified IC50 > 120.0 ug.mL-1 PMID[570533]
NPT485 Organism Plasmodium falciparum (isolate K1 / Thailand) Plasmodium falciparum K1 IC50 = 0.41 ug.mL-1 PMID[570534]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 0.43 ug.mL-1 PMID[570534]
NPT580 Organism Trypanosoma cruzi Trypanosoma cruzi IC50 = 6.8 ug.mL-1 PMID[570534]
NPT844 Organism Trypanosoma brucei rhodesiense Trypanosoma brucei rhodesiense IC50 = 0.7 ug.mL-1 PMID[570534]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC114257 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC299149
1.0 High Similarity NPC277710
1.0 High Similarity NPC153578
0.9763 High Similarity NPC87583
0.9759 High Similarity NPC475246
0.9758 High Similarity NPC85368
0.9699 High Similarity NPC3718
0.9697 High Similarity NPC30432
0.9697 High Similarity NPC76128
0.9697 High Similarity NPC111536
0.9697 High Similarity NPC271385
0.9697 High Similarity NPC5029
0.9641 High Similarity NPC46958
0.9591 High Similarity NPC105591
0.9586 High Similarity NPC475161
0.9586 High Similarity NPC477860
0.9581 High Similarity NPC68381
0.9576 High Similarity NPC222455
0.9524 High Similarity NPC475233
0.9521 High Similarity NPC203751
0.9458 High Similarity NPC259905
0.9455 High Similarity NPC178851
0.9412 High Similarity NPC212290
0.9408 High Similarity NPC289876
0.9408 High Similarity NPC102053
0.9405 High Similarity NPC98776
0.9405 High Similarity NPC213052
0.9401 High Similarity NPC298778
0.9357 High Similarity NPC315221
0.9349 High Similarity NPC146803
0.9302 High Similarity NPC475662
0.9302 High Similarity NPC473717
0.9302 High Similarity NPC313452
0.9302 High Similarity NPC473631
0.9302 High Similarity NPC293227
0.9298 High Similarity NPC58538
0.929 High Similarity NPC472054
0.929 High Similarity NPC199357
0.9277 High Similarity NPC478022
0.9277 High Similarity NPC478020
0.9273 High Similarity NPC146837
0.9273 High Similarity NPC278329
0.9273 High Similarity NPC101116
0.9273 High Similarity NPC212099
0.9273 High Similarity NPC216752
0.9244 High Similarity NPC85316
0.9244 High Similarity NPC197357
0.9235 High Similarity NPC63105
0.9235 High Similarity NPC470454
0.9235 High Similarity NPC199533
0.9235 High Similarity NPC470667
0.9235 High Similarity NPC474345
0.9235 High Similarity NPC186800
0.9205 High Similarity NPC264302
0.92 High Similarity NPC205721
0.9195 High Similarity NPC475352
0.9195 High Similarity NPC473686
0.9195 High Similarity NPC229817
0.9195 High Similarity NPC475220
0.9195 High Similarity NPC221140
0.9186 High Similarity NPC245059
0.9186 High Similarity NPC84494
0.9162 High Similarity NPC178281
0.9138 High Similarity NPC231254
0.9138 High Similarity NPC292706
0.9138 High Similarity NPC224557
0.9133 High Similarity NPC164047
0.9133 High Similarity NPC470453
0.9133 High Similarity NPC470448
0.9133 High Similarity NPC470452
0.9112 High Similarity NPC473202
0.9091 High Similarity NPC324736
0.9086 High Similarity NPC241847
0.9064 High Similarity NPC168789
0.9059 High Similarity NPC76047
0.9059 High Similarity NPC478021
0.9053 High Similarity NPC105414
0.9053 High Similarity NPC472058
0.9053 High Similarity NPC63470
0.9053 High Similarity NPC324522
0.9053 High Similarity NPC470341
0.9053 High Similarity NPC234497
0.9042 High Similarity NPC44947
0.904 High Similarity NPC314672
0.9036 High Similarity NPC472320
0.9034 High Similarity NPC65489
0.903 High Similarity NPC23817
0.9006 High Similarity NPC294501
0.9 High Similarity NPC470207
0.9 High Similarity NPC470206
0.8994 High Similarity NPC178173
0.8994 High Similarity NPC477835
0.8988 High Similarity NPC124155
0.8988 High Similarity NPC257566
0.8983 High Similarity NPC473618
0.8982 High Similarity NPC18380
0.8982 High Similarity NPC47923
0.8982 High Similarity NPC303913
0.8976 High Similarity NPC73511
0.8971 High Similarity NPC132111
0.897 High Similarity NPC78492
0.897 High Similarity NPC208152
0.8953 High Similarity NPC470336
0.8953 High Similarity NPC154986
0.8953 High Similarity NPC470335
0.8947 High Similarity NPC78734
0.8947 High Similarity NPC150767
0.8939 High Similarity NPC314459
0.8939 High Similarity NPC470199
0.8935 High Similarity NPC469664
0.8929 High Similarity NPC472876
0.8929 High Similarity NPC187934
0.8929 High Similarity NPC190450
0.8929 High Similarity NPC259834
0.8929 High Similarity NPC15374
0.8929 High Similarity NPC131745
0.8929 High Similarity NPC97637
0.8927 High Similarity NPC179947
0.8922 High Similarity NPC184326
0.8922 High Similarity NPC271479
0.8922 High Similarity NPC292863
0.8916 High Similarity NPC156457
0.8916 High Similarity NPC258035
0.8916 High Similarity NPC313163
0.8916 High Similarity NPC161749
0.8916 High Similarity NPC197896
0.8914 High Similarity NPC208797
0.8914 High Similarity NPC53680
0.8909 High Similarity NPC66508
0.8909 High Similarity NPC226656
0.8909 High Similarity NPC99233
0.8908 High Similarity NPC472387
0.8908 High Similarity NPC470334
0.8908 High Similarity NPC267549
0.8908 High Similarity NPC47191
0.8895 High Similarity NPC477836
0.8895 High Similarity NPC4200
0.8895 High Similarity NPC67134
0.8895 High Similarity NPC260263
0.8895 High Similarity NPC47140
0.8895 High Similarity NPC256760
0.8889 High Similarity NPC300307
0.8889 High Similarity NPC53252
0.8889 High Similarity NPC229687
0.8889 High Similarity NPC246274
0.8882 High Similarity NPC70441
0.8876 High Similarity NPC278419
0.8876 High Similarity NPC66087
0.8876 High Similarity NPC183672
0.8876 High Similarity NPC290160
0.8876 High Similarity NPC179198
0.887 High Similarity NPC111490
0.887 High Similarity NPC261623
0.8869 High Similarity NPC477629
0.8869 High Similarity NPC210961
0.8869 High Similarity NPC195685
0.8869 High Similarity NPC472994
0.8869 High Similarity NPC270675
0.8869 High Similarity NPC477628
0.8869 High Similarity NPC73148
0.8869 High Similarity NPC137232
0.8864 High Similarity NPC478001
0.8864 High Similarity NPC321916
0.8862 High Similarity NPC308265
0.8862 High Similarity NPC51760
0.8862 High Similarity NPC195167
0.8855 High Similarity NPC170475
0.8855 High Similarity NPC261866
0.8855 High Similarity NPC206378
0.8855 High Similarity NPC45165
0.8851 High Similarity NPC66820
0.8851 High Similarity NPC170018
0.8851 High Similarity NPC76112
0.8851 High Similarity NPC312630
0.8851 High Similarity NPC67629
0.8851 High Similarity NPC324220
0.8851 High Similarity NPC92403
0.8851 High Similarity NPC79736
0.8848 High Similarity NPC106625
0.8844 High Similarity NPC175230
0.8844 High Similarity NPC208668
0.8844 High Similarity NPC88560
0.8844 High Similarity NPC172033
0.8844 High Similarity NPC472993
0.884 High Similarity NPC470200
0.884 High Similarity NPC470197
0.884 High Similarity NPC470194
0.884 High Similarity NPC282474
0.884 High Similarity NPC470193
0.884 High Similarity NPC470195
0.884 High Similarity NPC316274
0.884 High Similarity NPC470198
0.884 High Similarity NPC470196
0.8837 High Similarity NPC105511
0.8837 High Similarity NPC313304
0.8837 High Similarity NPC231194
0.8837 High Similarity NPC52598
0.8837 High Similarity NPC287884
0.8837 High Similarity NPC204937
0.8837 High Similarity NPC241874

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC114257 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8982 High Similarity NPD6959 Discontinued
0.8953 High Similarity NPD6559 Discontinued
0.8927 High Similarity NPD7879 Clinical (unspecified phase)
0.8916 High Similarity NPD4381 Clinical (unspecified phase)
0.8851 High Similarity NPD8313 Approved
0.8851 High Similarity NPD8312 Approved
0.8779 High Similarity NPD7804 Clinical (unspecified phase)
0.8728 High Similarity NPD7074 Phase 3
0.8671 High Similarity NPD7054 Approved
0.8621 High Similarity NPD7472 Approved
0.8617 High Similarity NPD8151 Discontinued
0.8613 High Similarity NPD3818 Discontinued
0.8596 High Similarity NPD6232 Discontinued
0.8587 High Similarity NPD6776 Approved
0.8587 High Similarity NPD6777 Approved
0.8587 High Similarity NPD6779 Approved
0.8587 High Similarity NPD6778 Approved
0.8587 High Similarity NPD6780 Approved
0.8587 High Similarity NPD6782 Approved
0.8587 High Similarity NPD6781 Approved
0.8571 High Similarity NPD6797 Phase 2
0.8563 High Similarity NPD5844 Phase 1
0.8555 High Similarity NPD7473 Discontinued
0.8554 High Similarity NPD4380 Phase 2
0.8523 High Similarity NPD7251 Discontinued
0.8497 Intermediate Similarity NPD6166 Phase 2
0.8497 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8497 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8475 Intermediate Similarity NPD7808 Phase 3
0.8449 Intermediate Similarity NPD7435 Discontinued
0.8404 Intermediate Similarity NPD7870 Phase 2
0.8404 Intermediate Similarity NPD7871 Phase 2
0.8402 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8402 Intermediate Similarity NPD7819 Suspended
0.8398 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8391 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8371 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8363 Intermediate Similarity NPD7075 Discontinued
0.8353 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8351 Intermediate Similarity NPD7698 Approved
0.8351 Intermediate Similarity NPD7696 Phase 3
0.8351 Intermediate Similarity NPD7697 Approved
0.8315 Intermediate Similarity NPD6535 Approved
0.8315 Intermediate Similarity NPD6534 Approved
0.8304 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8295 Intermediate Similarity NPD3751 Discontinued
0.8284 Intermediate Similarity NPD7411 Suspended
0.8272 Intermediate Similarity NPD7701 Phase 2
0.8238 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.8238 Intermediate Similarity NPD7783 Phase 2
0.8235 Intermediate Similarity NPD1934 Approved
0.8201 Intermediate Similarity NPD6823 Phase 2
0.8187 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD7874 Approved
0.8187 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.8182 Intermediate Similarity NPD7699 Phase 2
0.8182 Intermediate Similarity NPD7700 Phase 2
0.8171 Intermediate Similarity NPD3787 Discontinued
0.8156 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8144 Intermediate Similarity NPD7801 Approved
0.8144 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8129 Intermediate Similarity NPD6801 Discontinued
0.8092 Intermediate Similarity NPD7768 Phase 2
0.8084 Intermediate Similarity NPD7390 Discontinued
0.8081 Intermediate Similarity NPD8455 Phase 2
0.8065 Intermediate Similarity NPD6213 Phase 3
0.8065 Intermediate Similarity NPD6212 Phase 3
0.8065 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.8059 Intermediate Similarity NPD3226 Approved
0.8057 Intermediate Similarity NPD5494 Approved
0.8046 Intermediate Similarity NPD3749 Approved
0.8036 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8021 Intermediate Similarity NPD8320 Phase 1
0.8021 Intermediate Similarity NPD8319 Approved
0.8 Intermediate Similarity NPD1549 Phase 2
0.7989 Intermediate Similarity NPD7228 Approved
0.7977 Intermediate Similarity NPD2801 Approved
0.7939 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7939 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7931 Intermediate Similarity NPD5402 Approved
0.7929 Intermediate Similarity NPD2533 Approved
0.7929 Intermediate Similarity NPD2532 Approved
0.7929 Intermediate Similarity NPD2534 Approved
0.7907 Intermediate Similarity NPD6599 Discontinued
0.7886 Intermediate Similarity NPD3882 Suspended
0.7874 Intermediate Similarity NPD1465 Phase 2
0.7871 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7849 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7849 Intermediate Similarity NPD7458 Discontinued
0.7829 Intermediate Similarity NPD3817 Phase 2
0.7818 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7816 Intermediate Similarity NPD37 Approved
0.7809 Intermediate Similarity NPD7199 Phase 2
0.7797 Intermediate Similarity NPD6234 Discontinued
0.7796 Intermediate Similarity NPD8150 Discontinued
0.7784 Intermediate Similarity NPD4967 Phase 2
0.7784 Intermediate Similarity NPD4965 Approved
0.7784 Intermediate Similarity NPD4966 Approved
0.7771 Intermediate Similarity NPD2796 Approved
0.7765 Intermediate Similarity NPD1511 Approved
0.7765 Intermediate Similarity NPD6799 Approved
0.7733 Intermediate Similarity NPD5403 Approved
0.7725 Intermediate Similarity NPD2346 Discontinued
0.7711 Intermediate Similarity NPD1510 Phase 2
0.7704 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD1607 Approved
0.7692 Intermediate Similarity NPD3750 Approved
0.7692 Intermediate Similarity NPD4628 Phase 3
0.7674 Intermediate Similarity NPD1512 Approved
0.7665 Intermediate Similarity NPD7584 Approved
0.7647 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7633 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.763 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7624 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD7240 Approved
0.7616 Intermediate Similarity NPD5401 Approved
0.7616 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7596 Intermediate Similarity NPD8058 Clinical (unspecified phase)
0.7596 Intermediate Similarity NPD8059 Phase 3
0.7588 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD1240 Approved
0.7574 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.756 Intermediate Similarity NPD5408 Approved
0.756 Intermediate Similarity NPD5405 Approved
0.756 Intermediate Similarity NPD5404 Approved
0.756 Intermediate Similarity NPD5406 Approved
0.7527 Intermediate Similarity NPD3926 Phase 2
0.7514 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD7003 Approved
0.7474 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7473 Intermediate Similarity NPD5710 Approved
0.7473 Intermediate Similarity NPD5953 Discontinued
0.7473 Intermediate Similarity NPD5711 Approved
0.7456 Intermediate Similarity NPD1551 Phase 2
0.7456 Intermediate Similarity NPD2935 Discontinued
0.7433 Intermediate Similarity NPD7685 Pre-registration
0.7429 Intermediate Similarity NPD920 Approved
0.7427 Intermediate Similarity NPD2800 Approved
0.7427 Intermediate Similarity NPD6674 Discontinued
0.7421 Intermediate Similarity NPD8434 Phase 2
0.7412 Intermediate Similarity NPD2344 Approved
0.7405 Intermediate Similarity NPD7177 Discontinued
0.7396 Intermediate Similarity NPD3748 Approved
0.7386 Intermediate Similarity NPD1653 Approved
0.7377 Intermediate Similarity NPD7229 Phase 3
0.736 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD6100 Approved
0.7353 Intermediate Similarity NPD6099 Approved
0.7349 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7322 Intermediate Similarity NPD1247 Approved
0.7314 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD8285 Discontinued
0.7308 Intermediate Similarity NPD919 Approved
0.7294 Intermediate Similarity NPD2799 Discontinued
0.7289 Intermediate Similarity NPD4625 Phase 3
0.7283 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7277 Intermediate Similarity NPD7585 Approved
0.7273 Intermediate Similarity NPD6273 Approved
0.7273 Intermediate Similarity NPD7286 Phase 2
0.7257 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD7680 Approved
0.7241 Intermediate Similarity NPD2309 Approved
0.7233 Intermediate Similarity NPD7930 Approved
0.7229 Intermediate Similarity NPD4908 Phase 1
0.7228 Intermediate Similarity NPD7583 Approved
0.7225 Intermediate Similarity NPD1243 Approved
0.7222 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7211 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7194 Intermediate Similarity NPD4363 Phase 3
0.7194 Intermediate Similarity NPD4360 Phase 2
0.7165 Intermediate Similarity NPD4287 Approved
0.716 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD1613 Approved
0.716 Intermediate Similarity NPD943 Approved
0.7152 Intermediate Similarity NPD1470 Approved
0.7143 Intermediate Similarity NPD2313 Discontinued
0.7143 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD7097 Phase 1
0.7128 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD7266 Discontinued
0.7076 Intermediate Similarity NPD6651 Approved
0.7045 Intermediate Similarity NPD6190 Approved
0.7043 Intermediate Similarity NPD8127 Discontinued
0.7042 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7028 Intermediate Similarity NPD8366 Approved
0.7018 Intermediate Similarity NPD1933 Approved
0.7018 Intermediate Similarity NPD230 Phase 1
0.7011 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.701 Intermediate Similarity NPD7999 Approved
0.7006 Intermediate Similarity NPD2798 Approved
0.6995 Remote Similarity NPD5761 Phase 2
0.6995 Remote Similarity NPD5760 Phase 2
0.6994 Remote Similarity NPD651 Clinical (unspecified phase)
0.6978 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6959 Remote Similarity NPD4060 Phase 1
0.6954 Remote Similarity NPD2438 Suspended
0.6941 Remote Similarity NPD3764 Approved
0.6941 Remote Similarity NPD6798 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data